Login / Signup

Botulinum Toxin Type A to Improve Facial Symmetry in Facial Palsy: A Practical Guideline and Clinical Experience.

Carla de Sanctis PecoraDanielle Shitara
Published in: Toxins (2021)
Unilateral peripheral facial nerve palsy jeopardizes quality of life, rendering psychological consequences such as low self-esteem, social isolation, anxiety, and depression. Among therapeutical approaches, use of Botulinum toxin type A (BoNT-A) on the nonparalyzed side has shown promising results and improvement of quality of life. Nevertheless, the correct technique is paramount, since over-injection of the muscles can result in lack of function, leading to a "paralyzed" appearance, and even worse, functional incompetence, which may cause greater distress to patients. Therefore, the objective of this article is to provide a practical guideline for botulinum toxin use in facial palsy. To this aim, adequate patient assessment, BoNT-A choice, injection plan and dosage, and injection techniques are covered.
Keyphrases
  • botulinum toxin
  • soft tissue
  • end stage renal disease
  • ultrasound guided
  • chronic kidney disease
  • ejection fraction
  • newly diagnosed
  • healthcare
  • peritoneal dialysis
  • prognostic factors
  • case report